HKTDC
The HKTDC Hong Kong International Jewellery Show and HKTDC Hong Kong International Diamond, Gem & Pearl Show will reach their 40th and 10th milestones respectively in 2024. The theme of this year’s event is Be Part of the Splendid Legacy. Apart from thanking all parties for their long-standing support, we hope to encourage more industry players to join this annual event and build the next milestone together.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240117430908/en/
Be Part of the Splendid Legacy Celebrating the Anniversary of Brilliance at the Twin Jewellery Shows The HKTDC Hong Kong International Jewellery Show and HKTDC Hong Kong International Diamond, Gem & Pearl Show will reach their 40th and 10th milestones respectively in 2024. The theme of this year’s event is Be Part of the Splendid Legacy. Apart from thanking all parties for their long-standing support, we hope to encourage more industry players to join this annual event and build the next milestone together. HKTDC Marketplace App launches a new feature, allowing buyers to register, upload photo and travel document for a verified eBadge. No more waiting in line nor verification required at the registration counter. Website for Marketplace App: http://tinyurl.com/mpj32df9 Websites for the twin jewellery shows Hong Kong International Jewellery Show: hkjewelleryshow.hktdc.com Hong Kong International Diamond, Gem & Pearl Show: hkdgp.hktdc.com (Photo: Business Wire)
|
Physical Fair |
Click2Match (AI-enabled online matching platform) |
The 2024 HKTDC Hong Kong International Jewellery Show (IJS) |
29 Feb – 4 Mar at Hong Kong Convention and Exhibition Centre |
20 Feb to 11 Mar |
The 2024 HKTDC Hong Kong International Diamond, Gem & Pearl Show (IDGPS) |
27 Feb – 2 Mar at AsiaWorld-Expo |
20 Feb to 11 Mar |
This year's IJS will feature splendid themed zones including the Hall of Extraordinary, Hall of Fame, and Designer Galleria. The Hall of Extraordinary will showcase high-end collections with stunning diamonds, precious stones, jadeite and pearls, from exhibitors representing Australia, Mainland China, Germany, Hong Kong, India, Italy, Japan, Switzerland, Thailand, the UK, and the US.
The Designer Galleria will showcase captivating collections from fashion-forward designers hailing from Austria, Mainland China, France, Hong Kong, Japan, Korea, Taiwan, Thailand, and the US.
Pavilions from several countries such as Mexico and Malaysia will return to the twin jewellery shows. The Hall of Fame will feature an impressive line-up of international brands, including Giorgio Visconti from Italy, Chete from Hong Kong, Carrera Y Carrera from Spain and Lao Feng Xiang from Mainland China.
The IDGPS will showcase the finest diamonds and pearls as well as quality gemstones and raw materials for jewellery from various origins in the Hall of Fine Diamond, Treasures of Nature and Treasures of Ocean.
The shows will also deliver an all-rounded programme with jewellery parades, seminars, buyer forums and networking events that bring trending market intelligence to industry players.
New feature of HKTDC Marketplace App
HKTDC Marketplace App launches a new feature, allowing buyers to register, upload photo and travel document for a verified eBadge. No more waiting in line nor verification required at the registration counter.
Website for Marketplace App:
http://tinyurl.com/kwkkpmmc
Websites for the twin jewellery shows
IJS: hkjewelleryshow.hktdc.com
IDGPS: hkdgp.hktdc.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240117430908/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Aesyra Demonstrates Significant Sleep Bruxism Reduction in Clinical Study26.1.2026 09:00:00 CET | Press release
Aesyra SA, a Swiss medtech company developing innovative digital therapeutics for dental and sleep-related disorders, today announced the successful completion of its clinical investigation evaluating the efficacy and safety of AesyBite™ Active, an intelligent oral appliance designed to treat and prevent sleep bruxism through biofeedback. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260126533019/en/ AesyBite Custom smart nightguard by Aesyra SA. The clinical investigation demonstrated that AesyBite™ Active achieved a statistically significant and clinically meaningful reduction in sleep bruxism activity, exceeding the predefined performance target. Strong and robust clinical outcomes In the study (Identifier: NCT06153810), involving 26 adult patients with confirmed sleep bruxism, activation of the AesyBite Active biofeedback system resulted in a 60.6% reduction in total sleep bruxism duration per hour compared to baseline
Franklin Templeton Aligns Alternative Credit Firms Under BSP Brand26.1.2026 08:58:00 CET | Press release
Benefit Street Partners and Alcentra align under a single, refreshed BSP brand.Move reflects client demand for a specialist, integrated and global credit platform.Franklin Templeton’s alternative credit platform on track to exceed $100bn in 2026.BSP outlines further growth plans including expansion in the Middle East and Asia.New research says 51% of institutional investors will increase credit allocation in 2026.81% of institutions say a specialist focus on credit is the top attribute for performance. Franklin Templeton’s US and European alternative credit businesses, Benefit Street Partners and Alcentra, have now aligned under an updated Benefit Street Partners (BSP) brand. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260123270080/en/ David Manlowe, CEO of Benefit Street Partners The move is the final step in BSP and Alcentra’s integration – two pioneering alternative credit firms that Franklin Templeton acquired in 2019
Samsung Epis Holdings Reports Fourth Quarter and Fiscal Year 2025 Financial Results26.1.2026 08:00:00 CET | Press release
In its first financial results announcement after the spin-off, Samsung Bioepis recorded FY2025 revenue of KRW 1.672 trillion, highest annual revenue in its 14-year historyExcluding milestone revenue, annual sales revenue grew 28% year-over-year (YoY), recording KRW 1.626 trillion, with 101% YoY growth in operating profit to KRW 330.8 billion Samsung Epis Holdings (KRX: 0126Z0), an investment company dedicated to innovations in biopharmaceuticals and biotechnology, today announced financial results for the fourth quarter and fiscal year 2025. “We are very pleased to report strong year-to-date sales growth in our first financial results following the spin-off. Our organic growth has been driven by solid performance across our biosimilars portfolio," said Kyung-Ah Kim, President and Chief Executive Officer (CEO) of Samsung Epis Holdings. “We are continuing to make meaningful progress in our regulatory and commercial milestones with our existing biosimilars portfolio, while strategically
Syngenta and Statkraft Sign Five-Year Virtual Power Purchase Agreement26.1.2026 08:00:00 CET | Press release
Virtual wind PPA with guarantees of origin to decarbonize Syngenta's plants in Europe Important element in carbon reduction journey for Syngenta AG Syngenta, one of the world’s biggest agricultural innovation companies, and Statkraft, a leading provider of innovative green energy solutions in Europe, have signed a virtual power purchase agreement (vPPA) covering Syngenta’s CP & Seeds operations for a period of five years. The volume amounts to 125 GWh per year and a total of 625 GWh of green electricity by the end of the contract in 2030. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260125701845/en/ Syngenta and Statkraft sign five-year virtual power purchase agreement With the vPPA, Statkraft is supporting Syngenta in advancing its sustainability strategy through the purchase of renewable energy. "This is Syngenta's first vPPA, marking a pivotal step in our decarbonization strategy," said Rachel Stenson Bugnon, Global Hea
Merz Therapeutics Submits Application to the European Medicines Agency for New Indication of XEOMIN® in Pediatric Spasticity26.1.2026 08:00:00 CET | Press release
Merz Therapeutics, a leading player in neurology-focused specialty pharma, today announced that it has completed the regulatory submission for XEOMIN® (incobotulinumtoxinA) for the treatment of spasticity of the lower and upper limb in children and adolescents aged 2–17 years in the European Union (EU) and European Economic Area (EEA). If approved, the indication would expand access to an established botulinum neurotoxin therapy for some of the youngest and most vulnerable patients across Europe. Spasticity is a common and often debilitating condition in children and adolescents with certain neurological conditions, leading to increased muscle tone that can significantly limit movement, function and independence. One of the most common underlying causes of spasticity in children is cerebral palsy (CP), the most frequent motor disability in childhood, with spastic forms accounting for approximately 80% of all cases. In more severe cases, spasticity associated with CP can also affect spe
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom